Evidence map›Paper›PMID 39136947›Full record

SynthesisJAMA network open2024

Patient-Reported Outcome Measures in Cancer Care: An Updated Systematic Review and Meta-Analysis.

Amaris K Balitsky, Daniel Rayner, Joanne Britto, Anath C Lionel, Lydia Ginsberg, Wanjae Cho, Ann Mary Wilfred, Huda Sardar, Nathan Cantor, Hira Mian and 2 more

Registry-linked trialAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07547163 (Patient Voice in the Treatment of Low-grade Gliomas), which is not on this map. Cited by 71 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07547163 recruitingnot on this mapstarted 2025, after this paper: background citation

Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared

TypeobservationalSponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaRan2025 to 2027Enrolled90ConditionsGlioma, Glioma of Brain, Low Grade Glioma of Brain, Low Grade GliomasArmsVorasidenib, Radiotherapy, active surveillance
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Health-related quality of life domains relevant to people in Europe undergoing cancer treatment: a systematic review of qualitative research.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Pooled it
  2. Barriers and facilitators for implementing patient-reported outcome measures in oncology practices: an umbrella review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Pooled it
  3. Pooled it
  4. Health-related quality of life in esophageal cancer: a state-of-the-art review of patient-reported outcomes and an evidence and gap map.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Pooled it
  5. Using Patient-Reported Outcome Measures to Identify Mobility Limitation in Incurable Cancer.Archives of rehabilitation research and clinical translation · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Quality of life assessment for colorectal cancer follow-up: A latent profile analysis of EORTC measures.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
    Article
  11. Febrile neutropenia in patients treated with chemotherapy/immune checkpoint inhibition: a MASCC consensus statement.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  12. Article
  13. Article
  14. The Effects of an Online Patient Portal on Nurses' and the Health Care Team's Work in an Outpatient Oncology Setting: A Qualitative Study.The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Integrating real-time patient-reported outcomes in colorectal cancer care: development and evaluation of a concise clinical scorecard.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  20. Qualitative study of patient-reported outcome data collection among clinicians in dermatology at a single academic center.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Amaris K BalitskyDepartment of Oncology, McMaster University, Hamilton, Ontario, Canada.
Daniel RaynerDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Joanne BrittoDepartment of Oncology, McMaster University, Hamilton, Ontario, Canada.
Anath C LionelDepartment of Oncology, McMaster University, Hamilton, Ontario, Canada.
Lydia GinsbergDepartment of Internal Medicine, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada.
Wanjae ChoMichael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Ann Mary WilfredSt George's University, School of Medicine, Grenada.
Huda SardarArizona College of Osteopathic Medicine, Midwestern University, Glendale.
Nathan CantorMichael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Hira MianDepartment of Oncology, McMaster University, Hamilton, Ontario, Canada.
Mark N LevineDepartment of Oncology, McMaster University, Hamilton, Ontario, Canada.
Gordon H GuyattDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Patient-reported outcome measures (PROMs) come directly from the patient, without clinician interpretation, to provide a patient-centered perspective. Objective: To understand the association of PROM integration into cancer care with patient-related, therapy-related, and health care utilization outcomes. Data Sources: Searches included MEDLINE and MEDLINE Epub ahead of print, in-process, and other nonindexed citations; Embase databases (OvidSP); PsychINFO; CENTRAL; and CINAHL from January 1, 2012 to September 26, 2022. Study Selection: Randomized clinical trials (RCTs) that enrolled adult patients (ages 18 years and older) with active cancer receiving anticancer therapy using a PROM as an intervention. Data Extraction and Synthesis: Pairs of review authors, using prepiloted forms, independently extracted trial characteristics, disease characteristics, and intervention details. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guideline was followed. Random-effects analyses were conducted. Main Outcomes and Measures: Overall mortality, health-related quality of life (HRQoL) measures, and hospital utilization outcomes. Results: From 1996 to 2022, 45 RCTs including 13 661 participants addressed the association of PROMs with outcomes considered important to patients. The addition of a PROM likely reduced the risk of overall mortality (HR, 0.84; 95% CI, 0.72-0.98; moderate certainty), improved HRQoL (range 0-100) at 12 weeks (mean difference [MD], 2.45; 95% CI, 0.42-4.48; moderate certainty). Improvements of HRQoL at 24 weeks were not significant (MD, 1.87; 95% CI, -1.21 to 4.96; low certainty). There was no association between the addition of a PROM and HRQoL at 48 weeks. The addition of a PROM was not associated with reduced ED visits (OR, 0.74; 95% CI, 0.54-1.02; low certainty) or hospital admissions (OR, 0.86; 95% CI, 0.73-1.02; low certainty). Conclusion and Relevance: The findings of this study suggest that the integration of PROMs into cancer care may improve overall survival and quality of life.

Indexed as

NeoplasmsPatient Reported Outcome MeasuresQuality of LifeAdultFemaleHumansMaleMiddle AgedRandomized Controlled Trials as Topic

Identifiers

PMID39136947
PMCPMC11322847

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.